Sort
78,016 grants matching “breast cancer”
Tribally Engaged Approaches to Lung Screening (TEALS)
$486,718Zsolt J Nagykaldi · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2021 · CA
Definition of Immune Infiltrate Phenotype and DNA Damage Response Deficits Across Diverse Murine Mammary Carcinomas
$486,710Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2019 · CA
BRCA1 and BRCA2: Homology-Directed DNA Repair and Breast Cancer
$486,708Maria Jasin · Sloan-Kettering Inst Can Research · P01 · FY2010 · CA
DECIPHERING THE ROLE OF ALTERNATIVE NON-HOMOLOGOUS END JOINING (ALT-NHEJ) DNA REPAIR IN BREAST CANCER
$486,684New York University · · FY2014 · Department of the Army
Molecular Diagnostics for Breast Cancer
$486,672University Of Utah · R33 · FY2002 · CA
Precision-exercise-prescription for Lung Cancer Patients Undergoing Surgery: The PEP Study
$486,664Cornelia M Ulrich · University Of Utah · R01 · FY2019 · CA
A NOVEL MOLECULAR MECHANISM REGULATING TRIPLE-NEGATIVE BASEL-LIKE BREAST CANCER: ROLE FOR LIM DOMAIN PROTEIN LMO2
$486,663The Leland Stanford Junior University · · FY2012 · Department of the Army
Microbes and Human Malignancies
$486,661James J Goedert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Understanding optimal delivery systems for cancer care
$486,648David C Miller · University Of Michigan At Ann Arbor · R01 · FY2014 · CA
Immunometabolic pathways enabled by PARP inhibition in breast cancer
$486,593Jennifer L. Guerriero · Brigham And Women'S Hospital · R37 · FY2025 · CA
Long-Term Adverse Outcomes Among Rural Cancer Survivors in a Population-Based Cohort
$486,574Mia Hashibe · University Of Utah · R01 · FY2021 · CA
Involution-based biomarkers of breast cancer risk
$486,563Derek C Radisky · Mayo Clinic Jacksonville · R01 · FY2023 · CA
Investigating the Role of Emergent Oscillations of Hypoxia Inducible Factor-1 alpha Activity in Cancer Growth and Progression
$486,550Fnu Kshitiz · University Of Connecticut Sch Of Med/Dnt · R37 · FY2023 · CA
Administrative Core
$486,543Mauro Ferrari · University Of Texas Hlth Sci Ctr Houston · U54 · FY2012 · CA
Role of Metalloproteinases in Mammary Gland Remodeling
$486,534University Of California San Francisco · R01 · FY2005 · CA
Proteolysis-targeting chimera against BCL-XL inhibits breast cancer metastasis
$486,504Weizhou Zhang · University Of Florida · R01 · FY2024 · CA
Project 04 - Develop a portfolio of agents for switching that match biology of residual tumor burden
$486,458Douglas Yee · University Of California, San Francisco · P01 · FY2017 · CA
Tyrosine Kinase-Dependant and - Independent Pathways of EGFR in Breast Cancer Pro
$486,323Mien-Chie Hung · University Of Tx Md Anderson Can Ctr · P01 · FY2013 · CA
Disseminating Breast Cancer Prevention to African American Women
$486,319Chanita A Hughes-Halbert · University Of Pennsylvania · R18 · FY2010 · HS
(PQC3) Genomic Diversity and Microenvironment as Drivers of Metastasis in DCIS
$486,312Eun-Sil Shelley Hwang · Duke University · R01 · FY2014 · CA
Multicenter Genetic, Epigenetic & Expression Analysis of DCIS outcome predictors
$486,308Christopher B Umbricht · Johns Hopkins University · R01 · FY2014 · CA
Targeted Sequencing of 3 Loci Associated with BMD in the Framingham Osteoporosis
$486,175Douglas P. Kiel · Hebrew Rehabilitation Center For Aged · R01 · FY2011 · AR
Bone Sparing Effects of Soy Phytoestrogens in Menopause
$486,167Silvina Levis · University Of Miami School Of Medicine · R01 · FY2008 · AR
Discriminatory Mechanisms in Early-Onset and Lethal Prostate Cancer
$486,167Barbara A Cohn · Public Health Institute · R01 · FY2024 · CA
Bay Area Tumor Institute CCOP
$486,165James Feusner · Bay Area Tumor Institute · U10 · FY2012 · CA